|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Protein Wnt-5a (aa 62–380) |
| WNT5A Swiss Prot# | | P41221 |
| WNT5A Protein names | | Protein Wnt-5a |
| WNT5A Gene names | | WNT5A |
| Organism | | Human |
| WNT5A Entry name | | WNT5A_HUMAN |
| WNT5A Codon optimized cDNA(gene) Clone |
| WNT5A Cat # | | RPE0655 |
| Tag | | WNT5A contains A 6x histidine tag |
| WNT5A Formulation | | Liquid |
| WNT5A Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| WNT5A Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant WNT5A Protein |
| WNT5A Cat # | | PE0655 |
| WNT5A Source | | recombinant |
| WNT5A Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| WNT5A Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| WNT5A Activity | | N/A |
| Tag | | WNT5A Contains A 6x histidine tag |
| WNT5A Formulation | | Liquid |
| WNT5A Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant WNT5A Products | | For pricing and availability Click Here >>> |
| WNT5A family | | Wnt family |
| WNT5A Subcellular locations | | Secreted > extracellular space > extracellular matrix. |
| WNT5A FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Can activate or inhibit canonical Wnt signaling, depending on receptor context. In the presence of FZD4, activates beta-catenin signaling. In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation through a GSK3-independent pathway which involves down-regulation of beta-catenin-induced reporter gene expression. Suppression of the canonical pathway allows chondrogenesis to occur and inhibits tumor formation. Stimulates cell migration. Decreases proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumor suppressor. Mediates motility of melanoma cells. Required during embryogenesis for extension of the primary anterior-posterior axis and for outgrowth of limbs and the genital tubercle. Inhibits type II collagen expression in chondrocytes. |
| WNT5A Sequence | | DDBJ | EMBL | GenBank |
| WNT5A 3D structure | | ModBase |
| WNT5A interaction | | STRING |
| WNT5A Proteomic | | PRIDE |
| WNT5A Genome annotation | | Ensembl | GeneID | KEGG | UCSC |
| WNT5A Organism specific | | CTD | MGI |
| WNT5A Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| WNT5A Gene expression | | Bgee | ArrayExpress | Genevestigator |
| WNT5A Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |